Cargando…
Development of an in vitro genotoxicity assay to detect retroviral vector-induced lymphoid insertional mutants
Safety assessment in retroviral vector-mediated gene therapy remains challenging. In clinical trials for different blood and immune disorders, insertional mutagenesis led to myeloid and lymphoid leukemia. We previously developed the In Vitro Immortalization Assay (IVIM) and Surrogate Assay for Genot...
Autores principales: | Bastone, Antonella L., Dziadek, Violetta, John-Neek, Philipp, Mansel, Friederike, Fleischauer, Jenni, Agyeman-Duah, Eric, Schaudien, Dirk, Dittrich-Breiholz, Oliver, Schwarzer, Adrian, Schambach, Axel, Rothe, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491817/ https://www.ncbi.nlm.nih.gov/pubmed/37693949 http://dx.doi.org/10.1016/j.omtm.2023.08.017 |
Ejemplares similares
-
TGFβ Inhibitor A83-01 Enhances Murine HSPC Expansion for Gene Therapy
por: Fleischauer, Jenni, et al.
Publicado: (2023) -
Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning
por: Schwarzer, Adrian, et al.
Publicado: (2021) -
Analyzing the Genotoxicity of Retroviral Vectors in Hematopoietic Cell Gene Therapy
por: Biasco, Luca, et al.
Publicado: (2017) -
Clonal Dominance With Retroviral Vector Insertions Near the ANGPT1 and ANGPT2 Genes in a Human Xenotransplant Mouse Model
por: Haemmerle, Reinhard, et al.
Publicado: (2014) -
Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation
por: Selich, Anton, et al.
Publicado: (2019)